You have to log in to have access to lightboxes
Monoclonal antibodies, shown here binding to a cell, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.
Monoclonal antibodies, shown here binding to a cell, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.
Monoclonal antibodies, shown here binding to a cell, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.
Monoclonal antibodies, shown here binding to a cell, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.
Monoclonal antibodies, shown here binding to a cell, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.
Monoclonal antibodies, shown here binding to a cell, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.
Monoclonal antibodies, shown here binding to a cell, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.
Monoclonal antibodies, shown here by itself with the antigens approaching the binding site, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.
Monoclonal antibodies, shown here by itself with the antigens approaching the binding site, are monospecific antibodies (these are antibodies that have an affinity for the same antigen) - mAB or moAb, as they are abbreviated, are the same because they are created by identical immune cells that are clones of a unique parent cell. Monoclonal antibodies are created to specifically bind to a substance so they can detect or purify that particular substance. In medications the non-proprietary drug name ends in -mab. Typically, monoclonal antibodies are produced by fusing myeloma cells with the spleen cells from a mouse and recently, as a result of advances, from rabbit B-cells. Monoclonals can be used as therapies for various serious diseases such as rheumatoid arthritis, multiple sclerosis and different cancers.